FORT LAUDERDALE, Fla., Sept. 1 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. , a leader in integrated electronic data capture (EDC) solutions for clinical trials, and one of the fastest growing companies in the EDC marketplace, announced today that three additional clinical research organizations (CRO) have joined its rapidly expanding partnership program, the CRO Preferred Program. The partnership allows CROs in the program to offer their clients the flexible, intuitive and robust EDC solution, TrialMaster(TM), for clinical trials. The CRO Preferred Program's distinct advantages include fixed pricing with no hidden fees, complete sales and marketing support from OmniComm, a dedicated hosted environment and comprehensive training and support for TrialMaster.
About OmniComm
OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc. has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey, the United Kingdom, and Russia as well as sales offices throughout the U.S. and Europe.
OmniComm Systems, Inc.
